DaVita
DVA
#1667
Rank
HK$100.38 B
Marketcap
HK$1,564
Share price
3.72%
Change (1 day)
38.08%
Change (1 year)
DaVita Inc. is an American company providing dialysis services for patients with chronic and acute kidney failure.

EPS for DaVita (DVA)

EPS in 2026 (TTM): HK$85.94

According to DaVita's latest financial reports the company's current EPS (TTM) is HK$86.13. In 2025 the company made an earnings per share (EPS) of HK$79.24 a decrease over its 2024 EPS that were of HK$86.37.

EPS history for DaVita from 2012 to 2026

Annual EPS

Year EPS Change
2026 (TTM)HK$85.948.45%
2025HK$79.24-8.25%
2024HK$86.3744.94%
2023HK$59.5927.26%
2022HK$46.82-35.56%
2021HK$72.6644.1%
2020HK$50.4319.7%
2019HK$42.13540.48%
2018HK$6.58-76.07%
2017HK$27.48-19.31%
2016HK$34.06242.52%
2015HK$9.94-62.87%
2014HK$26.7813.43%
2013HK$23.618.45%
2012HK$21.77

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Universal Health Services
UHS
HK$190.35 121.00%๐Ÿ‡บ๐Ÿ‡ธ USA
LabCorp
LH
HK$88.95 3.27%๐Ÿ‡บ๐Ÿ‡ธ USA
Tenet Healthcare
THC
HK$152.30 76.82%๐Ÿ‡บ๐Ÿ‡ธ USA
Pediatrix Medical Group
MD
HK$15.11-82.45%๐Ÿ‡บ๐Ÿ‡ธ USA